Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012. (British journal of haematology, 2014)

(untitled) - Reilly, J; McMullin, M; Beer, P; Butt, N; Conneally, E; Duncombe, A; Green, A; Mikhaeel, G; Gilleece, M; Knapper, S; Mead, A; Mesa, R; et al.